- Poster presentation
- Open Access
The early role of CMR in the assessment of cardiomyopathy
© Barrett and Waterhouse; licensee BioMed Central Ltd. 2012
- Published: 1 February 2012
- Cardiac Magnetic Resonance
- Cardiac Magnetic Resonance Imaging
- Angiographic Finding
- Cardiac Symptom
We performed a one year study to assess the impact of CMR imaging on the management of patients with suspected or confirmed cardiomyopathy.
Investigation and risk stratification of suspected or confirmed cardiomyopathy traditionally involves correlation between electrocardiographic, echocardiographic and angiographic findings in an appropriate clinical setting. Cardiac Magnetic Resonance (CMR) is the new gold standard in assessment of cardiac structure, function and perfusion, provided in a single study. Aetiology and prognostic factors may be investigated concurrently.
This was a single centre, 12-month experience of patients referred for assessment of presumptive cardiomyopathy. Images were provided by a 1.5T GE Scanner and were reported by a Level 3 Reporter.
224 patients (145 male, 79 female) underwent CMR assessment of cardiomyopathy. 177 (79%) were outpatient referrals.
The primary indications for CMR included
49 (21.9%) - Arrhythmia
42 (18.8%) - Abnormal echocardiogram with no cause found
35 (15.6%) - Cardiac symptoms with normal coronaries
32 (14.3%) - Screening for family history of CM/SCD
23 (10.3%) - Abnormal ECG/holter/stress test
18 (8%) - Follow-up of previously diagnosed CM
17 (7.6%) - Systemic illness
7(3.1%) - ICD insertion
CMR provided sufficient information to confirm or outrule cardiomyopathy in 68.2% of cases. A new diagnosis of cardiomyopathy was made in 25.4%. CMR also had an important role in ongoing assessment of patients with established diagnosis of cardiomyopathy, with 22.2% having their previous diagnosis outruled and 27.8% being recommended for device implantation as a direct result of CMR findings.
Overall in cardiomyopathy assessment, CMR had an impact on management in 50% of patients, with a therapeutic consequence on 36.2%, including medication changes, angiography and device insertion.
Patients at all stages of the clinical spectrum of cardiomyopathy, from initial presentation to institution of therapy and long-term follow up may benefit from CMR.
CMR should be implemented early in the diagnostis of suspected cardiomyopathy. Our data demonstrates the significant impact CMR consistently has on confirming diagnosis, guiding therapy and providing accurate prognosis in this patient group.
Male - 145
Female - 79
OPD - 177
Inpatient - 47
Mean - 26.7 kg/m2
StDev - 4.4 kg/m2
Mean - 63.4 years
StDev - 16.7 years
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.